{"id":162336,"url":"https://lda.senate.gov/api/v1/clients/162336/?format=json","client_id":12,"name":"ALLERGAN USA, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-04-30","registrant":{"id":63837,"url":"https://lda.senate.gov/api/v1/registrants/63837/?format=json","house_registrant_id":35518,"name":"ALLERGAN USA, INC.","description":"Pharmaceutical development and manufacturing","address_1":"500 North Capitol St., NW","address_2":"Suite 330","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT W. LIVELY","contact_telephone":"+1 202-550-2360","dt_updated":"2022-04-06T16:06:36.149726-04:00"}}